COVID-19: The Cochrane Methodology Review Group is, like other Cochrane Review Groups, identifying which reviews might be relevant to the response to COVID-19. We will seek to make the key information in these as available, accessible and understandable as possible. These will include our reviews on the effects of stategies to improve recruitment and retention in randomised trials, which may be relevant to trials of interventions for COVID-19, of interventions to mitigate the effects of the response to COVID-19 on other areas of health and social care, and of pre-existing trials that may now be struggling to continue or complete.
Relevant reviews are:
Strategies to improve recruitment to randomised trials
Strategies designed to help healthcare professionals to recruit participants to research studies
Strategies to improve retention in randomised trials
Cochrane has produced two special collections of reviews which are available from www.cochranelibrary.com. Evidence Aid is preparing COVID-19 summaries for relevant systematic reviews, which are available at www.evidenceaid.org/coronavirus-covid-19-evidence-collection (Mike Clarke, 25 March 2020).
The Cochrane Methodology Review Group is the Cochrane Review Group responsible for Cochrane methodology reviews. These are a special type of Cochrane review, examining the evidence on methodological aspects of systematic reviews, randomised trials and other evaluations of health and social care. They are published in the Cochrane Database of Systematic Reviews in the Cochrane Library, alongside Cochrane reviews of the effects of interventions, diagnostic test accuracy, prognosis and overviews of Cochrane reviews.
The Methodology Review Group has no dedicated funding but the editorial base for the Cochrane Methodology Review Group is based in the Northern Ireland Methodology Hub in Queen’s University of Belfast, Northern Ireland. If you would like to find out more about the Group, please contact the Co-ordinating Editor, Mike Clarke (firstname.lastname@example.org).